References
- Zadnik V, Primic Žakelj M, Lokar K, Jarm K, Ivanuš U, Žagar T. Cancer burden in Slovenia with the time trends analysis. Radiol Oncol 2017 22: 47-55. doi: 10.1515/raon-2017-0008.
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424. doi: 10.3322/caac.21492.
- Coleman MP, Alexe D, Albreht T, McKee M, eds. Responding to the challenge of cancer in Europe. Ljubljana: Institute of Public Health of the Republic of Slovenia; 2008.
- Primic-Žakelj M, Zadnik V, Žagar T, Zakotnik B. [Survival of cancer patients, diagnosed in 1991–2005 in Slovenia.]. [Slovenian and English]. Ljubljana: Instititute of Occology Ljubljana; 2009.
- Zadnik V, Žagar T, Lokar K, Tomšič S, Duratović-Konjević A, Zakotnik B. [Survival of cancer patients, diagnosed in 1997–2016 in Slovenia.]. [Slovenian and English]. Ljubljana: Instititute of Oncology Ljubljana; 2021 in press.
- CRRS. Cancer in Slovenia 2017. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia; 2020.
- Zadnik V, Primic Žakelj M, Žagar T. Linkage to supplementary registration sources: key lessons learned in the last 30 years in Slovenia. In: Benider A, Zanetti R, Siesling S, Bray F, editors. The 38th Annual IACR Conference. Marrakech: IACR; 2016.
- Pohar Perme M, Stare J, Esteve J. On estimation in relative survival. Biometrics 2012; 68: 113-20. doi: 10.1111/j.1541-0420.2011.01640.x.
- Pohar Perme M, Esteve J, Rachet B. Analysing population-based cancer survival – settling the controversies. BMC Cancer 2016; 16: 933. doi: 10.1186/s12885-016-2967-9.
- Zadnik V, Žagar T, Primic-Žakelj M. Cancer patients’ survival: standard calculation methods and some considerations regarding their interpretation. Zdrav Var 2016; 55: 134-41. doi: 10.1515/sjph-2016-0012.
- Pohar M, Stare J. Relative survival analysis in R. Computer Methods and Programs in Biomedicine 2006; 81: 272-8. doi: 10.1016/j.cmpb.2006.01.004.
- Pompe-Kirn V, Zakotnik B, Volk N, Benulič T, Škrk J. Cancer patients survival in Slovenia: 1963-1990. Ljubljana: Institute of Oncology Ljubljana; 1995.
- Pompe-Kirn V, Zakotnik B, Zadnik V, Serša G. Cancer patients survival in Slovenia: 1983-1997. Ljubljana: Institute of Oncology Ljubljana; 2003.
- Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 2018; 17: 1023-75. doi: 10.1016/S0140-6736(17)33326-3.
- Hayes JH, Barrey MJ. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA 2014; 311: 1143–9. doi: 10.1001/jama.2014.2085.
- Jarm K, Hertl K, Krajc M, Šval C, Kutnar V, Kuri r-Borovčić M et al. [Ten years of the National breast cancer screening programme Dora.]. [Slovenian]. Onkologija 2020; 24: 12-22. doi: 10.25670/oi2020-008on.
- Zadnik V, Žagar T. SLORA: Slovenia and cancer. Epidemiology and Cancer Registry. Institute of Oncology Ljubljana. (cited 2020 Dec 26). Available at www.slora.si
- Zakotnik B, Zadnik V, Žagar T, Primic-Žakelj M, Ivanuš U, Jerman T, et al. Reaching sustainable oncology care via the National Cancer Control Program (NCCP). Ann Oncol 2019; 30: v673. doi: /10.1093/annonc/mdz263.009.
- Zadnik V, Primic-Žakelj M, Žagar T. Cancer survival in children and adolescents in last 50 years in Slovenia. In: Grell. Grell 2017. Bruxelles: Belgian Cancer Registry; 2017.
- Česen Mazič M, Bonevski A, Mikeskova M, Mihut E, Bisogno G, Jazbec J. Treatment of rhabdomyosarcoma in children and adolescent from four low health expenditures average rates countries. Radiol Oncol 2020; 54: 455-60. doi: 10.2478/raon-2020-0059.
- De Angelis R, Sant M, Coleman MP, Francisi S, Baili P, Pierannunzio D, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 - a population-based study. Lancet Oncol 2013; 15: 23-34. doi: 10.1016/S1470-2045(13)70546-1.